114 related articles for article (PubMed ID: 8813961)
21. Negative cytology preceding cervical cancer: causes and prevention.
Robertson JH; Woodend B
J Clin Pathol; 1993 Aug; 46(8):700-2. PubMed ID: 8408692
[TBL] [Abstract][Full Text] [Related]
22. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of papanicolaou smears.
Djemli A; Khetani K; Case BW; Auger M
Cancer; 2006 Oct; 108(5):306-10. PubMed ID: 16948125
[TBL] [Abstract][Full Text] [Related]
23. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System.
Halford JA; Wright RG; Ditchmen EJ
Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730
[TBL] [Abstract][Full Text] [Related]
24. The sensitivity of rapid (partial) review of cervical smears.
Shield PW; Cox NC
Cytopathology; 1998 Apr; 9(2):84-92. PubMed ID: 9577734
[TBL] [Abstract][Full Text] [Related]
25. Comparison of false negative rates between 100% rapid review and 10% random full rescreening as internal quality control methods in cervical cytology screening.
Lee BC; Lam SY; Walker T
Acta Cytol; 2009; 53(3):271-6. PubMed ID: 19534266
[TBL] [Abstract][Full Text] [Related]
26. The characteristics of false negative cervical smears--implications for the UK cervical cancer screening programme.
Baker RW; O'Sullivan JP; Hanley J; Coleman DV
J Clin Pathol; 1999 May; 52(5):358-62. PubMed ID: 10560356
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of high grade dyskaryotic cervical smears likely to be missed on rapid rescreening.
O'Sullivan JP; Chapman PA; Jenkins L; Smith R
Acta Cytol; 2000; 44(1):37-40. PubMed ID: 10667157
[TBL] [Abstract][Full Text] [Related]
28. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases.
Renshaw AA
Cancer; 1997 Oct; 81(5):264-71. PubMed ID: 9349512
[TBL] [Abstract][Full Text] [Related]
29. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
Cernescu EC; Anton G; Ruţă S; Cernescu C
Roum Arch Microbiol Immunol; 2013; 72(2):93-104. PubMed ID: 24187808
[TBL] [Abstract][Full Text] [Related]
31. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
Kanber Y; Charbonneau M; Auger M
Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
[TBL] [Abstract][Full Text] [Related]
32. [Computer-assisted rescreening of cervicovaginal smears stained by the Papanicolaou method. Evaluation of the PAPNET system apropos of 225 cases].
Vuong PN; Vacher-Lavenu MC; Marsan C; Baviera E
Arch Anat Cytol Pathol; 1995; 43(3):147-53. PubMed ID: 7574913
[TBL] [Abstract][Full Text] [Related]
33. Rescreening in cervical cytology for quality control. When bad data is worse than no data or what works, what doesn't, and why.
Renshaw AA
Clin Lab Med; 2003 Sep; 23(3):695-708. PubMed ID: 14560535
[TBL] [Abstract][Full Text] [Related]
34. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing.
Currens HS; Nejkauf K; Wagner L; Raab SS
Am J Clin Pathol; 2012 Jan; 137(1):150-5. PubMed ID: 22180489
[TBL] [Abstract][Full Text] [Related]
36. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
[TBL] [Abstract][Full Text] [Related]
37. Role of re-screening of cervical smears in internal quality control.
Baker A; Melcher D; Smith R
J Clin Pathol; 1995 Nov; 48(11):1002-4. PubMed ID: 8543619
[TBL] [Abstract][Full Text] [Related]
38. Use of the ThinPrep Imaging System for internal quality control of cervical cytology.
Heard T; Chandra A; Culora G; Gupta SS; Herbert A; Morgan M
Cytopathology; 2013 Aug; 24(4):246-53. PubMed ID: 22937891
[TBL] [Abstract][Full Text] [Related]
39. An approach to the problem of false negatives in gynecologic cytologic screening.
Hindman WM
Acta Cytol; 1989; 33(6):814-8. PubMed ID: 2686323
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
